Because of your risk of getting PML while you receive TYSABRI, TYSABRI is available only through a restricted distribution program called the TOUCH®Prescribing Program Who should not receive TYSABRI? Do not receive TYSABRI if youhave PML or are allergic to natalizumab or any of the ingredients ...
Because of your risk of getting PML while you receive TYSABRI, TYSABRI is available only through a restricted distribution program called the TOUCH® Prescribing Program Who should not receive TYSABRI? Do not receive TYSABRI if you have PML or are allergic to natalizumab or any of the ingredient...
泰萨布里的药物标签中须包括一个黑框警告,提醒PML的风险。另外,除了严格执行TOUCH计划外,渤健还要做一项上市后临床研究,跟踪至少5000名患者最少5年。 图5. BIIB股价在27个月(2004年10月–2006年12月)内的走势图 数据来源:finance.yahoo.com 12 前行...
Because of your risk of getting PML while you receive TYSABRI, TYSABRI is available only through a restricted distribution program called the TOUCH® Prescribing Program Who should not receive TYSABRI? Do not receive TYSABRI if you have PML or are allergic to natalizumab or any of the ingredient...
REMS: Prescribe With TOUCH® Not an actual patient. Neuro QoL Infusion Center Locator Coverage & Reimbursement More than 20 years of clinical trial and real-world experience1-3 OVER1,000,000PATIENT-YEARS OF EXPERIENCE treating patients with RMS ...
（3）2组有0.5%的患者出现钆（Gd）增强T1病变。NOVA研究是在对TOUCH处方项目进行分析之后启动的，旨在评估Tysabri Q6W IV给药方案的疗效。TOUCH处方项目分析显示，延长的给药间隔与PML概率的显著降低相关。来自TOUCH研究的最新数据分析表明，与批准的Q4W IV方案相比，平均Q6W给药方案与PML概率降低88%相关（危险比0...
Because of your risk of getting PML while you receive TYSABRI, TYSABRI is available only through a restricted distribution program called the TOUCH® Prescribing Program Who should not receive TYSABRI? Do not receive TYSABRI if you have PML or are allergic to natalizumab or any of the ingredient...
Bases of the reintroduction; Reason for the drug's suspension; Elements of the TOUCH program developed by the Administration's Peripheral and Central Nervous Systems Drug Advisory Committee to ensure the proper use of Tysabri.doi:10.2165/00128415-200611060-00006None...
5.2.TYSABRITOUCHPrescribingProgram TYSABRIisavailableonlythrougharestrictedprogramunderaREMScalledtheTOUCH® PrescribingProgrambecauseoftheriskofPML[seeWarningsandPrecautions(5.1)]. ReferenceID: ® Forprescribersandpatients,theTOUCHPrescribingProgramhastwocomponents:MS ®® TOUCH(forpatientswithmultiplesclerosis)...
TYSABRI TOUCH®Prescribing Program TYSABRI is available only through a restricted program under a REMS called the TOUCH®Prescribing Program because of the risk of PML [seeProgressive Multifocal Leukoencephalopathy]. For prescribers and patients, the TOUCH®Prescribing Program has two components: MS...